Therapeutics: Heat shock protein 90 (Hsp90); transcription factor A mitochondrial (TFAM; TCF6)

Cancer

INDICATION: Melanoma

Cell culture and mouse studies suggest inhibiting mitochondrial Hsp90 or TFAM could help treat BRAF-mutant melanoma

Read the full 175 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE